









| Ingredient format | What is primarily defined | What to confirm before comparison |
|---|---|---|
| Standardized extract | A specified level or range of selected markers or components | Marker or active, assay basis, method, plant source, carrier or adjustment materials |
| Ratio or concentrated extract | Relationship between starting plant material and resulting native preparation, often expressed as a DER or ratio | Ratio definition, native versus finished material, process details, carrier, and any separate assay |
| Botanical powder or whole herb | Milled plant material rather than a selectively concentrated preparation | Species, plant part, identity, mesh, microbial controls, and intended formulation role |
| Liquid herbal extract or tincture | Plant-to-liquid relationship and preparation system | Strength, liquid composition, solids, and dosage-form suitability |



| Plant example | Specification language a buyer may encounter | Qualification focus |
|---|---|---|
| Milk thistle | Silymarin or a defined flavonolignan profile | Plant part, assay basis, method, full profile |
| Ginkgo | Flavonoid glycosides and terpene lactones | Refined form, marker ranges, unwanted-compound limits |
| St. John’s wort | Hypericin and/or hyperforin | Preparation type, marker rationale, market-specific review |
| Echinacea | Alkylamides or other constituent groups | Species, root versus aerial part, method |
| Ginseng | Ginsenosides | Panax species, plant part, processing, assay basis |
| Saw palmetto | Total fatty acids and/or sterols | Fruit source, process, lipid profile, method |
| Kava | Kavalactones | Plant part, preparation, process, destination-market requirements |
No. A standardized extract is controlled to a defined level or range of a marker compound, active constituent, or component group. A ratio extract describes the relationship between the starting botanical material and finished extract. Some ingredients may include both an extract ratio and an assay specification, but the two values describe different product characteristics.
No. The stated compound is one measured component within a more complex botanical extract. An assay such as a percentage or defined range does not mean the remaining material is inactive, nor does it establish clinical efficacy. Buyers should review the complete specification, extraction information, carrier content where applicable, and analytical basis.
A marker compound is used to identify, quantify, or monitor consistency in an extract. An active constituent has evidence linking it to a biological effect. A marker should not automatically be treated as an active constituent; its role depends on the botanical, available evidence, specification, and analytical method.
Yes. Extracts with similar assay values may differ in botanical species, plant part, extraction process, solvent system, botanical-to-extract ratio, carrier content, constituent profile, particle characteristics, or test method. Commercial comparison should therefore be based on the complete specification rather than the assay percentage alone.
Depending on the ingredient and supplier, buyers may request a product specification, lot-specific certificate of analysis, technical data sheet, safety data sheet, analytical method reference, country-of-origin information, processing details, and relevant contaminant or regulatory documentation. Required documents should be confirmed for the intended application and destination market.
Provide the botanical or ingredient name, species and plant part where applicable, target marker or active constituent specification, preferred analytical method, physical form, intended application, destination market, forecast quantity, packaging requirements, and required technical documents. Include any sample or formulation-review requirements that may affect qualification.